Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 17, 2005 - Issue 7-8
426
Views
70
CrossRef citations to date
0
Altmetric
Research Article

Dosimetric Adjustments for Interspecies Extrapolation of Inhaled Poorly Soluble Particles (PSP)

, &
Pages 317-334 | Accepted 19 Jan 2005, Published online: 06 Oct 2008

REFERENCES

  • Anjilvel S., Asgharian B. A multiple-path model of particle deposition in the rat lung. Fundam. Appl. Toxicol. 1995; 28: 41–50, [PUBMED], [INFOTRIEVE], [CSA]
  • Asgharian B. A model of deposition of hygroscopic particles in the human lung. Aerosol Sci. Technol. 2004; 38: 938–947, [CROSSREF]
  • Asgharian B., Hofmann W., Bergmann R. Particle deposition in a multiple-path model of the human lung. Aerosol Sci. Technol. 2001a; 34: 332–339
  • Asgharian B., Hofmann W., Miller F. J. Mucociliary clearance of insoluble particles from the tracheobronchial airways of the human lung. J. Aerosol Sci. 2001b; 32: 817–832, [CROSSREF]
  • Asgharian B., Wong B. A., Bermudez E., Everitt J. I. A model of clearance of titanium dioxide from the rat lung. Toxicologist 2001c; 60(1)195
  • Asgharian B., Kelly J. T., Tewksbury E. W. Respiratory deposition and inhalability of monodisperse aerosols in Long-Evans rats. Toxicol. Sci. 2003; 71: 104–111, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Asgharian B., Ménache M. G., Miller F. J. Modeling age-related particle deposition in humans. J. Aerosol Med. 2004; 17(3)213–224, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Bailey M. R., Ansoborlo E., Guilmette R. A., Paquet F. Practical applications of the ICRP human respiratory tract model. Radiat. Protect. Dosim. 2003a; 105(1–4)71–76
  • Bailey M. R., Ansoborlo E., Camner P., Chazel V., Fritsch P., Hodgson A., Kreyling W. G., Le Gall B., Newton D., Paquet F., Stradling N., Taylor D. M. RBDATA-EULEP: Providing information to improve internal dosimetry. Radiat. Protect. Dosim. 2003b; 105(1–4)633–636
  • Bermudez E., Mangum J. B., Asgharian B., Wong B. A., Reverdy E. E., Janszen D. B., Hext P. M., Warheit D. B., Everitt J. I. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol. Sci. 2002; 70: 86–97, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bogdanffy M. S., Jarabek A. M. Understanding mechanisms of inhaled toxicants: implications for replacing default factors with chemical-specific data. Toxicol. Lett. 1995; 82/83: 919–932, [CROSSREF]
  • Bogdanffy M. S., Daston G., Faustman E. M., Kimmel C. A., Kimmel G. L., Seed J., Vu V. Harmonization of cancer and noncancer risk assessment: Proceedings of a consensus-building workshop. Toxicol. Sci. 2001; 61: 18–31, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cassee F. R., Muijser H., Duistermaat E., Freijer J. J., Geerse K. B., Marijnissen J. C. M., Arts J. H. E. Particle-size dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch. Toxicol. 2002; 76: 277–286, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • CIIT Centers for Health Research. Multiple path particle dosimetry model MPPD 2004, v. 2.0.
  • Clarke R. W., Catalano P. J., Koutrakis P., Krishna M. G. G., Sioutas C., Paulauskis J., Coull B., Ferguson S., Godleski J. J. Urban air particulate inhalation alters pulmonary function and induces pulmonary inflammation in a rodent model of chronic bronchitis. Inhal. Toxicol. 1999; 11: 637–656, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Clewell H. J., Gentry P. R., Covington T. R., Sarangapani R., Teeguarden J. G. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. 2004; 79: 381–393, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Conolly R. B., Kimbell J. S., Janszen D., Schlosser P. M., Kalisak D., Preston J., Miller F. J. Biologically-motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Toxicol. Sci. 2003; 75: 432–447, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Conolly R. B., Kimbell J. S., Janszen D., Schlosser P. M., Kalisak D., Preston J., Miller F. J. Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci. 2004; 8: 1–18
  • Dahl A. R., Schlesinger R. B., Heck H. d'A., Medinsky M. A., Lucier G. W. Comparative dosimetry of inhaled materials: Differences among animal species and extrapolation to man. Fundam. Appl. Toxicol. 1991; 16: 1–13, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • DeLorme M. P., Moss O. R. Comparison of restrained and unrestrained whole-body plethysmographs for mice. J. Pharmacol. Toxicol. Methods 2002; 47: 1–10, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Dormans J. A. M. A., Steerenberg P. A., Arts. J. H. E., Van Bree L., De Klerk A., Verlann A. P. J., Bruijntjes J. P., Beekhof P., Van Soolingen D., Van Loveren H. Pathological and immunological effects of respirable coal fly ash in male Wistar rats. Inhal. Toxicol. 1999; 11: 51–69, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Driscoll K. E., Deyo L. C., Carter J. M., Howard B. W., Hassenbein D. G., Bertram T. A. Effects of particule exposure and particle-elicited inflammatory cells on mutation in rat alveolar type II cells. Carcinogenesis 1997; 18: 23–430, [CSA], [CROSSREF]
  • Duffin R., Tran C. L., Clouter A., Brown D. M., MacNee W., Stone V., Dondaldson K. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann. Occup. Hyg. 2002; 46(supp l.1)242–245
  • Ghio A. J., Kim C., Devlin R. B. Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am. J. Respir. Crit. Care Med. 2000; 162: 981–988, [PUBMED], [INFOTRIEVE], [CSA]
  • Gong H., Sioutas C., Linn W. S., Clark K. W., Terrell S. L., Terrell L. L., Anderson K. R., Kim S., Chang M.-C. Controlled human exposures to concentrated ambient fine particles in metropolitan Los Angeles: Methodology and preliminary health-effect findings. Inhal. Toxicol. 2000; 12(suppl. 1)107–119, [CROSSREF]
  • Greim H., Borm P., Schins R., Donaldson K., Driscoll K., Hartwig A., Kuempel E., Oberdörster G., Speit G. Toxicity of fibers and particles—Report of the workshop held in Munich, Germany, 26–27 October 2000. Inhal. Toxicol. 2001; 13(9)737–754, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Haber F. Zur geschichte des gaskrieges (On the history of gas warfare). Fünf Vorträge aus den Jahren 1920–1923 (Five lectures from years 1920–1923). Springer, Berlin 1924; pp. 76–92
  • Hatch T., Choate S. P. Statistical description of the size properties of non-uniform particulate substances. J. Franklin Inst. 1929; 207: 369–387, [CROSSREF]
  • Heyder J., Beek-Speier I., Busch B., Dirscherl P., Heilmann P., Ferron G. A., Josten M., Karg E., Kreyling W. G., Lenz A.-G., Maier K. L., Miaskowski U., Platz S., Reitmeir P., Schulz H., Takenaka S., Ziesenis A. Health effects of sulfur-related environmental air pollution. I. Executive summary. Inhal. Toxicol. 1999; 11: 343–359, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hofmann W., Bergmann R. Predictions of particle deposition patterns in human and rat airways. Inhal. Toxicol. 1998; 10: 557–583, [CROSSREF]
  • Hofmann W., Koblinger L. The effect of polydispersity of radioactive aerosols on the activity distribution in the human lung. J. Aerosol. Sci. 1989; 20: 1313–1316, [CROSSREF]
  • International Commission on Radiological Protection. Human respiratory tract model for radiological protection. ICRP Publication 66. Annals ICRP 1994; 24: 1–3, [CSA]
  • International Life Sciences Institute. ILSI Risk Science Institute Workshop: The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus resport. Inhal. Toxicol. 2000; 12(1–2)1–17, [CSA]
  • Jarabek A. M. Inhalation RfC methodology: dosimetric adjustments and dose-response estimation of noncancer toxicity in the upper respiratory tract. Inhal. Toxicol. 1994; 6(suppl. l)301–325
  • Jarabek A. M. Interspecies extrapolation based on mechanistic determinants of chemical disposition. Hum. Ecol. Risk Assess. 1995a; 1(5)641–662
  • Jarabek A. M. Consideration of temporal toxicity challenges current default approaches. Inhal. Toxicol. 1995b; 7: 929–946
  • Jarabek A. M. The application of dosimetry models to identify key processes and parameters for default dose-response assessment approaches. Toxicol. Lett. 1995c; 79: 171–184, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jarabek A. M. Mode of action: Framework for dosimetry model development. Presented at Mode-of-Action Dosimetry: An Interagency Project to Develop Models for Inhalation, Oral, and Dermal Disposition, Annual Meeting of the Society for Risk Analysis, Arlington, VA, December, 4–62000, Abstract available online at http://www.sra.org.
  • Jarabek A. M., Ménache M. G., Overton J. H., Jr., Dourson M. L., Miller F. J. Inhalation reference Dose (RfDi): An application of interspecies dosimetry modeling for risk assessment of insoluble particles. Health. Phys. 1989; 57(suppl. 1)177–183, [PUBMED], [INFOTRIEVE]
  • Jarabek A. M., Ménache M. G., Overton J. H., Jr., Dourson M. L., Miller F. J. The U.S. Environmental Protection Agency's inhalation RfD methodology: Risk assessment for air toxics. Toxicol. Ind. Health 1990; 6: 279–301, [PUBMED], [INFOTRIEVE], [CSA]
  • Killingsworth C. R., Alessandrini F., Krishna Murthy G. G., Catalano P. J., Paulauskis J. D., Godleski J. J. Inflammation, chemokine expression, and death in monocrotaline-treated rats following fuel oil fly ash inhalation. Inhal. Toxicol. 1997; 9: 541–565, [CROSSREF]
  • Kimbell J. S., Subramaniam R. P., Gross E. A., Schlosser P. M., Morgan K. T. Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol. Sci. 2001; 64: 100–110, [PUBMED], [INFOTRIEVE], [CSA]
  • Kimbell J. S., Kalisak D. L., Conolly R. B., Miller F. J., Jarabek A. M. A mechanistic model of lifetime cancer risk for inhalation exposures to reactive gases. Toxicol. Sci. 2004
  • Koblinger L., Hofmann W. Analysis of human lung morphometric data for stochastic aerosol deposition calculations. Phys. Med. Biol. 1985; 30: 541–556, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Koblinger L., Hofmann W. Monte Carlo modeling of aerosol deposition in human lungs. Part I: Simulation of particle transport in a stochastic lung structure. J. Aerosol Sci. 1990; 21: 661–674, [CSA], [CROSSREF]
  • Kodavanti U. P., Schladweiler M. C., Ledbetter A. D., Watkinson W. P., Campen M. J., Winsett D. W., Richards J. R., Crissman K. M., Hatch G. E., Costa D. L. The spontaneously hypertensive rat as a model of human cardiovascular disease: Evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter. Toxicol. Appl. Pharmacol. 2000; 164: 250–263, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ménache M. G., Miller F. J., Raabe O. G. Particle inhalability curves for humans and small laboratory animals. Ann. Occup. Hyg. 1995; 39(3)317–328, [CSA], [CROSSREF]
  • Miller F. J. Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: A critical review. Inhal. Toxicol. 2000; 12(1–2)19–58, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Miller F. J., Martonen T. B., Ménache M. G., Graham R. C., Spektor D. M., Lippmann M. (1988) Influence of breathing mode and activity level on the regional deposition of inhaled particles and implications for regulatory standards. Inhaled particles VI: Proceedings of an international symposium and workshop on lung dosimetry, CambridgeUnited Kingdom, September, 1985, J. Dodgson, R. I. McCallum, M. R. Bailey, D. R. Fisher, Ann. Occup. Hyg. 32(suppl. 1):3-10
  • Miller F. J., Anjilvel S., Ménache M. G., Asgharian B., Gerrity T. R. (1995) Dosimetric issues relating to particulate toxicity. Proceedings of the colloquium on particulate air pollution and human mortality and morbidity, Part II, Irvine, CA, January, 1994, R. F. Phalen, D. V. Bates, Inhal. Toxicol. 7:615–632
  • Miller F. J., Schlosser P. M., Jansen D. B. Haber's rule: A special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint. Toxicologist 2000; 149: 21–34, [CROSSREF]
  • Morrow P. E. Possible mechanisms to explain dust overloading of the lungs. Fundam. Appl. Toxicol. 1988; 10: 369–384, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Moss O. R., Cheng Y.-S. Generation and characterization of test atmospheres: Particles. Concepts in inhalation toxicology, R. O. McClellan, R. F. Henderson. Hemisphere, New York 1989; pp. 85–120
  • National Council on Radiation Protection and Measurements. Deposition, retention and dosimetry of inhaled radioactive substances. NCRP, Bethesda, MD 1997, NCRP Report 125
  • Oberdörster G. (1996) Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Particle overload in the rat lung and lung cancer: Implications for human risk assessment, Proceedings of a conference held at the Massachusetts Institute of Technology. March, 29–301996, J. L. Mauderley, R. J. McCunney. Taylor & Francis, Washington, DC, pp. 73–90
  • Oberdörster G. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal. Toxicol. 2002; 14(1)29–56, [CSA], [CROSSREF]
  • Oberdörster G., Ferin J., Lehnert B. E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 1994; 102(suppl. 5)173–179
  • Raabe O. G., Yeh H.-C., Schum G. M., Phalen R. F. Tracheobronchial geometry: Human, dog, rat, hamster. Lovelace Foundation, Albuquerque, NM 1976, Report LF-53
  • Raabe O. G., Yeh H.-C., Newton G. J., Phalen R. F., Velasquez D. J. (1977) Deposition of inhaled monodisperse aerosols in small rodents. Inhaled particles IV, Part I: Proceedings of an international symposium, EdinburghScotland, September, 1977, W. H. Walton, B. McGovern. Pergamon Press, OxfordU.K., pp. 3–21
  • Raabe O. G., Al-Bayati M. A., Teague S. V., Rasolt A. (1988) Regional deposition of inhaled monodisperse, coarse, and fine aerosol particles in small laboratory animals. Inhaled particles VI: Proceedings of an international symposium and workshop on lung dosimetry, CambridgeUnited Kingdom, September, 1985, J. Dodgson, R. I. McCallum, M. R. Bailey, D. R. Fischer, Ann. Occup. Hyg. 32(suppl. 1):53–63
  • Rudolf G. A mathematical model for the deposition of aerosol particles in the human respiratory tract. J. Aerosol Sci. 1984; 15: 195–199
  • Schlesinger R. B. Comparative deposition of inhaled aerosols in experimental animals and humans: A review. J. Toxicol. Environ. Health 1985; 15: 197–214, [PUBMED], [INFOTRIEVE]
  • Schroeter J. D., Musante C. J., Hwang D., Burton R., Guilmette R., Martonen T. B. Hygroscopic growth and deposition of inhaled secondary cigarette smoke in human nasal pathways. Aerosol Sci. Technol. 2001; 34: 137–143
  • Segal R. A., Martonen T. B., Kim C. S., Shearer M. Computer simulations of particle deposition in the lungs of chronic obstructive pulmonary disease patients. Inhal. Toxicol. 2002; 14: 705–720, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Snipes M. B., James A. C., Jarabek A. M. The 1994 ICRP66 human respiratory tract model as a tool for predicting lung burdens from exposures to environmental aerosols. Appl. Occup. Environ. Hyg. 1997; 12(8)547–554, [CSA]
  • Stöber W., Morrow P. E., Koch W., Morawietz G. Alveolar clearance and retention of inhaled insoluble particles in rats simulated by a model inferring macrophage particle load distributions. J. Aerosol Sci. 1994; 25(5)975–1002, [CSA], [CROSSREF]
  • Stone K. C., Mercer R. R., Gehr P., Stockstill B., Crapo J. D. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell. Mol. Biol. 1992; 6: 235–243, [PUBMED], [INFOTRIEVE]
  • Subramaniam R. P., Asgharian B., Freijer J. I., Miller F. J., Anjilvel S. Analysis of lobar differences in particle deposition in the human lung. Inhal. Toxicol 2003; 15(1)1–21, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tran C. L., Buchanan D., Cullen R. T., Searl A., Ones A. D., Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal. Toxicol. 2000a; 12: 1113–1126, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tran C. L., Buchanan D., Miller B. G., Jones A. D. Mathematical modeling to predict the response to poorly soluble particles in rat lungs. Inhal. Toxicol. 2000b; 12(3)403–409
  • U.S. Environmental Protection Agency. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. Office of Research and Development, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Research Triangle Park, NC 1994, Report EPA/600/8-90/066F. Final. October.
  • U.S. Environmental Protection Agency. The use of the benchmark dose in health risk assessment. Office of Research and Development, Risk Assessment Forum, Washington, DC 1995, EPA/630/R94/007
  • U.S. Environmental Protection Agency. Dosimetry of inhaled particles in the respiratory tract. Air quality criteria for particulate matter. Office of Research and Development, Washington, DC 1996; vol. II of III, chap. 10. EPA/600/P-95/001bF. April
  • U.S. Environmental Protection Agency. Revised cancer guidelines for carcinogen risk assessment. Office of Research and Development, Risk Assessment Forum. 1999, NCEA_F-0644. External review draft.
  • U.S. Environmental Protection Agency. Dosimetry of particulate matter. Air quality criteria for particulate matter. Office of Research and Development, Washington, DC 2004; vol II of II, chap. 6. EPA 600P-99/002bF.
  • Wiltse J. A., Dellarco V. L. U.S. Environmental Protection Agency's revised guidelines for carcinogen risk assessment: Evaluating a postulated mode of carcinogenic action in guiding dose-response extrapolation. Mutat. Res. 2000; 464: 105–115, [PUBMED], [INFOTRIEVE]
  • Wolff R. K. Mucociliary function. Treatise on pulmonary toxicology: Comparative biology of the normal lung, R. A. Parent. CRC Press, Boca Raton, FL 1992; vol. I, chap, 35
  • Yeh H.-C., Schum G. M. Models of human lung airways and their application to inhaled particle deposition. Bull. Math. Biol. 1980; 42: 461–480, [PUBMED], [INFOTRIEVE]
  • Yeh H.-C., Schum G. M., Duggen M. T. Anatomic models of the tracheobronchial and pulmonary regions of the rat. Anat. Rec. 1979; 195: 483–492, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Yu C. P. Extrapolation modeling of particle deposition and retention from rats to humans. Inhal. Toxicol. 1996; 8(suppl.)279–291
  • Zhang L., Yu C. P. Empirical equations for nasal deposition of inhaled particles in small laboratory animals and humans. Aerosol Sci. Technol. 1993; 19: 51–56, [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.